Bruker Corporation (BRKR)
NASDAQ: BRKRIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
BRKR stock chart
Technical analysisKey statistics
All statistics- Market cap
- $9.10B
- Forward P/E
- 24.96
- EPS (TTM)
- -$0.70
- Dividend yield
- 0.33% ($0.20)
- Ex-dividend date
- Sep 21, 2026
- 52-week range
- 32.37 – 66.98
- Day range
- 57.33 – 61.38
- Volume / Avg
- 2.91M / 2.21M
- Beta
- —
- Shares outstanding
- 152.36M
- Next earnings
- Nov 2, 2026
52-week range
BRKR stock today
On Oct 7, BRKR ended the session at $59.72, shedding $0.78 (1.29%), versus the S&P 500's 0.22% decline. Shares are 10.8% below their 52-week high of $66.98, set on Sep 30, 2026 and 84.5% above the 52-week low of $32.37, in the middle of the past year's range. BRKR is up 26.8% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 72.8%.
Bruker has posted a net loss over the last twelve months (EPS of -$0.70), so its P/E ratio is not meaningful. Bruker's next earnings report is expected on Nov 2, 2026. Bruker pays an annual dividend of $0.20 per share, a 0.33% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Bruker
Company profileBruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions.
- Sector
- Industrials
- Industry
- Biotechnology: Laboratory Analytical Instruments
- CEO
- Dr. Frank H. Laukien Ph.D.
- Headquarters
- Billerica, MA
- Employees
- 11,085
- Website
- bruker.com
Financial highlights
Full financialsIn fiscal 2025, Bruker generated $3.44 billion in revenue, up 2.1% from fiscal 2024, its 5th consecutive year of revenue growth. Bruker reported a net loss of $8.6 million, compared with net income of $113.1 million a year earlier. Gross margin was 45.9% (down from 49.0%) and operating margin 2.0%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $3.44B | $3.37B | $2.96B | $2.53B | $2.42B |
| Growth | +2.08% | +13.56% | +17.14% | +4.67% | +21.66% |
| Net income | $-8.60M | $113.10M | $427.20M | $296.60M | $277.10M |
| EPS (diluted) | $-0.15 | $0.76 | $2.90 | $1.99 | $1.81 |
Analyst forecast
ForecastConsensus (13 analysts)
buy
Avg. price target
$63.25+5.91%
- Strong buy 2
- Buy 5
- Hold 5
- Sell 1
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 2, 2026
- EPS estimate
- $0.42
- Last reported (Q2 2026)
- Aug 5, 2026
- EPS actual vs est.
- $-0.41 vs —
Dividends
Dividend history- Annual dividend
- $0.20
- Dividend yield
- 0.33%
- Last payment
- $0.05
- Ex-dividend date
- Sep 21, 2026
BRKR news
All BRKR newsBruker peers
Industrials sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| BIOBio-Rad Laboratories Inc. Class A | 367.92 | -0.25% | $9.84B | vs BRKR |
| TXG10x Genomics Inc. Class A | 76.10 | -5.65% | $9.92B | vs BRKR |
| AVTRAvantor Inc. | 15.35 | -0.52% | $10.38B | vs BRKR |
| ALMRAlamar Biosciences Inc. | 27.77 | -13.92% | $1.93B | vs BRKR |
| RVTYRevvity Inc. | 153.60 | +0.20% | $17.14B | vs BRKR |
| PACBPacific Biosciences of California Inc. | 2.72 | +0.74% | $845.46M | vs BRKR |
| CTKBCytek Biosciences Inc. | 5.34 | -0.74% | $694.11M | vs BRKR |
| EYPTEyePoint Inc. | 3.32 | +4.73% | $278.35M | vs BRKR |
Indexes, lists and sector
Appears in lists
Bruker stock FAQ
What is Bruker's stock price today?
BRKR last traded at $59.72 as of Oct 7, 4:00 PM EDT, down 1.29% on the day. Prices are delayed at least 15 minutes.
Does Bruker pay a dividend?
Yes. Bruker pays $0.20 per share annually, a 0.33% yield. The most recent dividend of $0.05 had an ex-dividend date of Sep 21, 2026.
When is Bruker's next earnings date?
Bruker is expected to report earnings on Monday, November 2, 2026. Analysts expect EPS of $0.42.
Who is Bruker's CEO?
Dr. Frank H. Laukien Ph.D. is the chief executive officer of Bruker Corporation, which has about 11,085 employees.
What is the BRKR 52-week high?
The 52-week high for BRKR is $66.98 and the 52-week low is $32.37. The stock is currently 10.8% below its high.